Clinical Trial Update: Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing CELBESTA and CELEBREX in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CELBESTA
• CELEBREX (Celecoxib)

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED